Rodney W. Nichols

PP.10 Date:October 3, 1994 Chief Executive Officer New York Academy of Sciences New York City "I rely upon THE SCIENTIST's lively reporting of hot scientific trends and complex issues raised by the changing R&D environment. THE SCIENTIST covers unconventional angles that shorter reports in daily newspapers and science weeklies don't reveal." As head of the New York Academy of Sciences (NYAS), Rodney Nichols dedicates his time to

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PP.10
Date:October 3, 1994

Chief Executive Officer
New York Academy of Sciences
New York City

"I rely upon THE SCIENTIST's lively reporting of hot scientific trends and complex issues raised by the changing R&D environment. THE SCIENTIST covers unconventional angles that shorter reports in daily newspapers and science weeklies don't reveal."

As head of the New York Academy of Sciences (NYAS), Rodney Nichols dedicates his time to advancing research and analyzing how science and technology can best serve society. An applied physicist and policy analyst, Nichols says: "My colleagues and I work to develop a balanced view of the scientific community's needs and responsibilities and to promote wise and effective applications of research. We aim to ensure the strenght of the scientific and engineering enterprise for the next generation."

Founded in 1817 and the United States' third oldest scientific organizaiton, NYAS serves scientists, engineers, and physicians worldwide by offering aobut ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies